Compile Data Set for Download or QSAR
Report error Found 150 Enz. Inhib. hit(s) with all data for entry = 10950
TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580509(US11492341, Compound I-24)
Affinity DataIC50: 500nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580560(US11492341, Compound I-55)
Affinity DataIC50: 500nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580530(US11492341, Compound I-44)
Affinity DataIC50: 500nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580654(US11492341, Compound I-159)
Affinity DataIC50: 500nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580567(US11492341, Compound I-62)
Affinity DataIC50: 500nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580519(US11492341, Compound I-34)
Affinity DataIC50: 500nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580612(US11492341, Compound I-104)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580613(US11492341, Compound I-105)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580610(US11492341, Compound I-102)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580611(US11492341, Compound I-103)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580618(US11492341, Compound I-111)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580619(US11492341, Compound I-112)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580626(US11492341, Compound I-121)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580593(US11492341, Compound I-88)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580594(US11492341, Compound I-89)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580591(US11492341, Compound I-86)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580592(US11492341, Compound I-87)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580597(US11492341, Compound I-92)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580598(US11492341, Compound I-93)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580595(US11492341, Compound I-90)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580596(US11492341, Compound I-91)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580601(US11492341, Compound I-96)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580602(US11492341, Compound I-97)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580599(US11492341, Compound I-94)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580600(US11492341, Compound I-95)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580608(US11492341, Compound I-100)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580609(US11492341, Compound I-101)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580603(US11492341, Compound I-98)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580604(US11492341, Compound I-99)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580646(US11492341, Compound I-151)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580647(US11492341, Compound I-152)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580644(US11492341, Compound I-149)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580645(US11492341, Compound I-150)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580651(US11492341, Compound I-156)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580648(US11492341, Compound I-153)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580649(US11492341, Compound I-154)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580655(US11492341, Compound I-160)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580652(US11492341, Compound I-157)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580653(US11492341, Compound I-158)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580658(US11492341, Compound I-163)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580656(US11492341, Compound I-161)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580657(US11492341, Compound I-162)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580630(US11492341, Compound I-135)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580631(US11492341, Compound I-136)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580629(US11492341, Compound I-127)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580634(US11492341, Compound I-139)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580635(US11492341, Compound I-140)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580632(US11492341, Compound I-137)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580633(US11492341, Compound I-138)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580638(US11492341, Compound I-143)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

Displayed 1 to 50 (of 150 total ) | Next | Last >>
Jump to: